Related Experiment Videos

Assessment of Growth Disturbance in Japanese Children with IBD

Tetsuo Shono1, Mayuko Kato, Yo Aoyagi

  • 1Department of Pediatrics, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

International Journal of Pediatrics
|May 11, 2010
PubMed

Insights

Growth retardation in pediatric inflammatory bowel disease (IBD) patients in Japan is linked to chronic inflammation and corticosteroid use. Early intervention is crucial for managing growth disturbances in children with Crohn

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease (IBD) Research
  • Growth and Development Studies

Background:

  • Limited data exists on growth retardation in pediatric IBD patients in Japan.
  • Understanding the factors contributing to growth issues in pediatric IBD is crucial for effective management.

Purpose of the Study:

  • To investigate the causes of growth retardation in Japanese children diagnosed with Crohn's disease (CD) and ulcerative colitis (UC).
  • To identify potential correlations between growth parameters, inflammatory markers, and corticosteroid treatment in pediatric IBD.

Main Methods:

  • Retrospective analysis of height, body weight, and serum biomarkers (albumin, IGF-I, CRP, cytokines) in 15 CD and 18 UC patients.
  • Assessment of corticosteroid dosage administered to the pediatric IBD cohort.
  • Comparison of growth parameters and biochemical markers between CD and UC patients.

Main Results:

  • Growth retardation was observed in pediatric CD patients even before their initial clinical visit.
  • Chronic inflammation appears to be a significant factor contributing to growth disturbances in pediatric IBD.
  • Corticosteroid (PSL) administration may negatively impact growth by reducing serum IGF-I levels.

Conclusions:

  • Growth retardation is an early complication in Japanese children with Crohn's disease, likely driven by chronic inflammation.
  • Corticosteroid therapy may exacerbate growth issues in pediatric IBD by affecting Insulin-like Growth Factor I (IGF-I) levels.
  • Further research is warranted to optimize treatment strategies for growth management in pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...